Sociedad Americana de Hirudoterapia

Drug Regulatory Authority of Pakistan

DRAP · Pakistan · asia pacific

Regulatory jurisdiction profileJurisdictional reference
Unregulatednational regulator

Pakistan's Drug Regulatory Authority — federal authority over therapeutic goods; leech-specific regulatory pathway has not been independently verified by ASH.

Regulatory Profile

Agency type
national regulator
Region
asia pacific
Country
Pakistan
Leech status
unregulated
Last ASH review
2026-05-25

Relevant Regulation Codes

  • Drug Regulatory Authority of Pakistan Act, 2012
  • Pakistani national medical-device regulatory framework

Prescriber Requirements

  • PMC (Pakistan Medical Commission)-registered MD prescription required
  • Traditional medicine (Tibb) and complementary medicine practitioner scope under the National Council for Tibb / National Council for Homoeopathy for hirudotherapy not independently verified by ASH

Supply Chain & GMP

DRAP product registration if classified as a medical device; English and Urdu-language labelling.

Import/Export Rules

DRAP import licence plus Department of Plant Protection / animal quarantine clearance for live invertebrates; CITES Appendix II paperwork.

Reimbursement Context

Sehat Sahulat Programme and provincial social health insurance coverage for hirudotherapy not independently verified by ASH.

ASH Editorial Notes

Pakistan has a long-standing Tibb (Unani) traditional medicine tradition with statutory recognition via the National Council for Tibb; whether leech therapy is regulated as a Tibb modality or as a medical device under DRAP has not been independently verified by ASH.

Related Jurisdictions

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.